▪ 제   목 : A Model-Based Cost-Effectiveness Analysis of Long-Acting Monoclonal Antibody (Tixagevimab and Cilgavimab: Evusheld) Preventive Treatment for High-Risk Populations Against SARS- CoV-2 in Korea

▪ 저   자 : Youngji Jo, Sun Bean Kim, Jaehun Jung*

▪ 저널명 : JOURNAL OF KOREAN MEDICAL SCIENCE (IF=4.5, JCR 2022 기준)

▪ 게재정보 : 2023 Aug 14;38(32):e250. 

▪ ISSN : 1011-8934

▪ DOI : 10.3346/jkms.2023.38.e250